This report is intended to provide an overview of trends and developments in the in IVD industry as it applies to emerging markets and the BRIC countries in particular.

A Realistic Look at the Market for IVD in New, Emerging Markets

A good number of reports on the BRIC and emerging markets have been published. Most of these focus on quantitative data such as number of labs, hospitals, product registration regulations, and import taxes and conditions. Too many of them perhaps present merely a growth scenario without presenting the challenges the nations face and the challenges the countries face entering the market. This report provides much of this information because it provides an objective overview of the market for in vitro diagnostics in selected countries. This report also explores the opportunities that specific developing countries offer to IVD companies.

Kalorama also attempts to add some realistic aspects of working in a foreign country that are more qualitative in nature. Thus the report explores some of the cultural aspects of how the market for clinical diagnostics may evolve in a selection of emerging markets including the BRIC countries.

Useful Information for Business Planning

The discussion of each of the BRIC markets begins with a short introduction to the country and follows with a SWOT analysis of the market for IVDs. The SWOT analysis provides positive and negative aspects of market conditions. The author has decided to include positive and negative aspects of certain factors in the same SWOT category. The factors are classed positive or negative according to the strength of current market conditions. This is done to make the analysis comprehensive and easier to read.

The report covers data trends and issues, including:

Healthcare trends and metrics in each country
Physician Office Testing (POL) in BRIC Countries
Disease Trends (Diabetes, Cancer, Allergy, Emerging Viruses)
Lab Systems in BRIC Countries
SWOT Analysis for Each BRIC Nation, Including:
Strengths - factors that make the country attractive for IVD companies
Weaknesses that form barriers to entry and success such as health insurance coverage, regulatory affairs and distribution issues
Country Elements that Provide Testing Opportunities
Threats - a look at the competition and incumbents
Key Companies Operating in Each Country
Research and High Technology in BRIC countries
Other Trends (Insurance, Medical Tourism, Recession Effects )

Market and economic trends are discussed from the point of view of their present and potential impact and there is a focus on the mix of economics, healthcare and diagnostics that may evolve in these countries.

Table of Contents :

CHAPTER ONE: EXECUTIVE SUMMARY
Scope and Methodology
Emerging Market Trends
World Demand for Diagnostics
CHAPTER TWO: INTRODUCTION
Background
Population Trends and Disease Demographics
Disease Trends
Diabetes
Cancer
Allergy
Emerging Viruses
Market Segment Opportunities
Physician Office Testing (POL)
Lab Systems
Research and High Technology
Insurance Trends
Medical Tourism
Recession Effects
CHAPTER THREE: OVERVIEW AND BRIC COMPARISON
Background
The BRIC Metrics
Available Market
Culture of Paying for Healthcare
Capacity to Serve
IVD Spending
China and India - The BRIC Engines
CHAPTER FOUR: CHINA: MARKET TRENDS/DEMAND ANALYSIS
Introduction
Strengths - Factors That Make the Country Attractive
Weaknesses - Factors That Offer Barriers to Market Success and Entry

For more information kindly visit :
http://www.bharatbook.com/detail.asp?id=202747&rt=Emerging-Markets-for-In-Vitro-Diagnostics-IVD-in-Brazil-Russia-India-China-and-Other-Nations.html

Related Reports
Global Credit Card Industry - Emerging Markets
http://www.bharatbook.com/detail.asp?id=85222&rt=Global-Credit-Card-Industry-Emerging-Markets.html

Cardiac Medical Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
http://www.bharatbook.com/detail.asp?id=174261&rt=Cardiac-Medical-Devices-Emerging-Markets-Brazil-Russia-India-China-South-Africa-And-South-Korea2009-2015.html